Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2025-12-25 @ 10:33 PM
Study NCT ID:
NCT05217667
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-10
First Post:
2022-01-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)
Sponsor:
Arrowhead Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-11
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-20
First Submit QC Date:
None
Study First Post Date:
2022-02-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-08-22
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-10
Last Update Post Date Type:
ESTIMATED